$1.78
-0.24-11.85%
At Close: -
$1.78
-0.0050-0.28%
After Hours: 5:42 PM EDT
15 minutes delayed
Regulus Therapeutics
RGLSNASDAQ
Regulus Therapeutics (NASDAQ:RGLS) Stock, Earnings Estimates, EPS, And Revenue
Regulus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 6
EPS Estimate
$-0.130
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Regulus Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RGLS | Regulus Therapeutics | -$0.37 | -$0.13 | — | — | $0.00 | — | — | — | 08/06/2024 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.42 | -$0.21 | -$0.29 | -38.10% | $0.00 | — | $0.00 | — | 05/09/2024 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.40 | -$0.39 | -$0.40 | -2.56% | $0.00 | — | $0.00 | — | 03/21/2024 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.50 | -$0.40 | -$0.40 | 0.00% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.50 | -$0.41 | -$0.37 | 9.76% | $0.00 | — | $0.00 | — | 08/08/2023 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.50 | -$0.44 | -$0.42 | 4.55% | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.70 | -$0.51 | -$0.40 | 21.57% | $0.00 | — | $0.00 | — | 03/23/2023 | Get Alert |
| RGLS | Regulus Therapeutics | -$1.00 | -$0.49 | -$0.50 | -2.04% | $0.00 | — | $0.00 | — | 11/10/2022 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.80 | -$0.50 | -$0.50 | 0.00% | $0.00 | — | $0.00 | — | 08/11/2022 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.80 | -$0.50 | -$0.50 | 0.00% | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.30 | -$0.70 | -$0.70 | 0.00% | $5.00M | — | $0.00 | — | 03/10/2022 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.40 | -$0.80 | -$1.00 | -25.00% | $5.00M | — | $0.00 | — | 11/10/2021 | Get Alert |
| RGLS | Regulus Therapeutics | -$2.30 | -$0.80 | -$0.80 | 0.00% | $0.00 | $10.00K | $0.00 | -100.00% | 08/10/2021 | Get Alert |
| RGLS | Regulus Therapeutics | -$2.50 | -$0.90 | -$0.80 | 11.11% | $6.00K | $20.00K | $0.00 | -100.00% | 05/13/2021 | Get Alert |
| RGLS | Regulus Therapeutics | -$2.30 | — | -$0.30 | — | $18.00K | — | $5.00M | — | 03/09/2021 | Get Alert |
| RGLS | Regulus Therapeutics | -$2.60 | -$2.10 | -$0.40 | 80.95% | $18.00K | $340.00K | $5.00M | 1370.59% | 11/05/2020 | Get Alert |
| RGLS | Regulus Therapeutics | -$3.00 | — | -$2.30 | — | $18.00K | — | $0.00 | — | 08/13/2020 | Get Alert |
| RGLS | Regulus Therapeutics | -$3.10 | — | -$2.50 | — | $6.78M | — | $6.00K | — | 05/14/2020 | Get Alert |
| RGLS | Regulus Therapeutics | -$9.80 | — | -$2.30 | — | $18.00K | — | $18.00K | — | 03/12/2020 | Get Alert |
| RGLS | Regulus Therapeutics | -$11.80 | — | -$2.60 | — | $18.00K | — | $18.00K | — | 11/12/2019 | Get Alert |
| RGLS | Regulus Therapeutics | -$15.60 | — | -$3.00 | — | $18.00K | — | $18.00K | — | 08/08/2019 | Get Alert |
Regulus Therapeutics (RGLS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-0.29 | $-0.21 | -38.1 % |
| Dec 2023 | 2024-03-21 | $-0.40 | $-0.39 | -2.56 % |
| Sep 2023 | 2023-11-09 | $-0.40 | $-0.40 | 0.00 % |
| Jun 2023 | 2023-08-08 | $-0.37 | $-0.41 | 9.76 % |
Regulus Therapeutics (RGLS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2021 | 2021-08-10 | $0 | $10.00K | -100.0 % |
| Mar 2021 | 2021-05-13 | $0 | $20.00K | -100.0 % |
| Sep 2020 | 2020-11-05 | $5.00M | $340.00K | 1370.6 % |
FAQ
When is Regulus Therapeutics (NASDAQ:RGLS) reporting earnings?
Regulus Therapeutics (RGLS) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Regulus Therapeutics (NASDAQ:RGLS)?
The Actual EPS was $-0.29, which missed the estimate of $-0.21.
What were Regulus Therapeutics’s (NASDAQ:RGLS) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.